Bio Green Med Solution (BGMS) Cash & Equivalents Growth (3y) (2013 - 2026)
Powered by 
Analysis
Bio Green Med Solution (BGMS) Cash & Equivalents Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.80 Bn | 133.95 Bn | 2.84 Bn | -15.41% |
| 2 | Regeneron Pharmaceuticals | 86.58 Bn | 78.59 Bn | 3.93 Bn | 8.23% |
| 3 | Argenx Se | 64.98 Bn | 59.79 Bn | 1.37 Bn | 47.78% |
| 4 | Moderna | 57.34 Bn | 52.20 Bn | 52.00 Mn | -23.18% |
| 5 | Revolution Medicines | 44.46 Bn | 44.46 Bn | - | - |
| 6 | BeOne Medicines | 40.34 Bn | 35.24 Bn | 1.53 Bn | 14.34% |
| 7 | Alnylam Pharmaceuticals | 35.50 Bn | 32.19 Bn | 992.69 Mn | 37.45% |
| 8 | Royalty Pharma | 28.15 Bn | 27.32 Bn | - | -27.97% |
| 9 | Insmed | 27.50 Bn | 26.34 Bn | 358.27 Mn | -3.85% |
| 10 | Bio Green Med Solution | 5.01 Mn | 1.22 Mn | 79,000.00 | -28.11% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -28.11% |
| Mar 31, 2026 | -33.66% |
| Dec 31, 2025 | -42.40% |
| Sep 30, 2025 | -45.50% |
| Jun 30, 2025 | -47.13% |
| Mar 31, 2025 | -50.94% |
| Dec 31, 2024 | -55.89% |
| Sep 30, 2024 | -57.91% |
| Jun 30, 2024 | -48.39% |
| Mar 31, 2024 | -61.16% |
| Dec 31, 2023 | -53.41% |
| Sep 30, 2023 | -36.42% |
| Jun 30, 2023 | -26.17% |
| Mar 31, 2023 | 8.62% |
| Dec 31, 2022 | 15.57% |
| Sep 30, 2022 | 22.28% |
| Jun 30, 2022 | 24.28% |
| Mar 31, 2022 | 18.23% |
| Dec 31, 2021 | 27.83% |
| Sep 30, 2021 | 28.46% |